UBX - upcoming catalysts - This is not a financial advice!
Most info on the chart.
We might seeing a pullback first before further upmove.
Trade carefully!
0YC0 trade ideas
UBX - Education/Training ChartSee my comments as shown in the chart and leave any questions or comments below.
This stock is a great learning example of what to look for to spot trends and patterns.
NOTE: I am staying Neutral on this stock as to not give a clue on the potential Target Price.
UNITY Biotechnology Announces Positive Data in Phase 2UBX: Unity Biotechnology, Inc.
2022-08-12 07:00:00 UNITY Biotechnology Announces Positive Data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
UBX ( NASDAQ BIOTECH PENNY) crushes earnings and news catalystNASDAQ:UBX
and rises over 100 % in premarket, Has a new product
for macular degeneration, a widespread medical problem
affecting vision in the elderly which is increasing
in incidence. The earning beat was significant.
Chart demonstrates the uptrend and midrange
RSI but does not show today's premarket.
40 % rise in the week leading up to earnings and now parabolic.
doubling overnight.
* Get in the party now, don't be late. If you are
late stay home"
( not a recommendation to buy only education)
long Term trade PT 6+ Hello, just sharing a idea of a company I ran across that looks like its in falling wedge formation with positive earnings to boot and at a all time low.
Invest like Jeff Bezos & Peter Thiel, buy longevity stocks.Have you ever wondered what you like to buy with your money if you were super-rich?
Maybe buy something that would make you live longer?
Well the problem is that doesn't really exist yet, which is why people are/should invest in this company 😃
www.cnbc.com
There are different longevity-related stocks, but this one seems to be the one currently that looks most promising.
The reason is that the "Long Now" Jeff Bezos and "Venture capitalist" Peter Thiel is behind it.
I personally see this as a long-term play, especially now that BioTech is starting to get momentum.
$UBX Long-Term Target $18.90Unity Biotechnology is a pharmaceutical company focused on creating a drug that will extend the years people can live unburdened by disease. This drug has shown a great deal of promise and is currently in phase two clinical trials. As the trials progress, we can expect the price to rise dramatically, and given the current uptrend, My forecast is $18.90 by May 2022. However, that could just be the beginning. This stock is not very popular yet, as it is very few hedge funds. This means that if phase two goes well, Unity Biotech could grow to ridiculous prices. We could be looking at the next AMGN or VRTX. This company is an extremely good investment. Like and follow for more biotech ideas :) Happy Trading!
Anti-aging biotech is looking super juicy meow meow style!I don't invest in Pharma, and this isn't Pharma! As I understand it, the company is making implants to help counter the aging process. Very future, very cool!
I think this could be a very good week for this stock!
As always, this is not investment advice!
UBX BuyyyUBX is hitting styrong support and we should see a bounce for the next few weeks. This stock has huge potential.
UBX Likely to See $9 Again SoonUnity Biotechnology shares almost hit $10 a couple of weeks ago, and since peaking they have shed almost a third of their value, finding support in the process. I have been a long-term investor in UBX for around four months now, and I bought additional shares on Friday because of this stellar entry point. UBX has been very reliable in past months with this support line, and I think shares could easily push up to $12 this month. For the short term I am targeting around $9.90. Good Luck!
UBX LongTaking a UBX long here at 7. 40 . Hard support at this level. Also confirmed with the 0.618 FIB level.
UBX Developing Revolutionary DrugWhat if I told you you could slow your aging dramatically by simply taking a pill? UBX has been working on this for a very long time, and they have showed promise in their trials. The risk could be somewhat high, but you could be looking at a potential 20,000% upside if they are successful.
UBX: Long, 450% profitThe price of UBX dropped over 60% after the announcement of bad results of the study of UBX0101 (treatment for knees osteoarthritis). Despite these bad results, UNITY Biotechnology has great potential since they do not focus only on one study. For example, they work on UBX1325, a treatment focused on retinal disease. In the last announcement, they state that they have enough money to fund operations well into 2022.
Enter price: Market
Price target: $15 or even more
This is an idea, but not advice.
$UBX Unity Biotechnology, Inc. Pennant formedUnity Biotechnology, Inc. operates as a biotechnology company engaged in the research and development of therapeutics to extend the human health span. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi and Daohong Zhou on March 30, 2009 and is headquartered in Brisbane, CA.
18% short interest
Average analysts price target $21.00 | BUY
Seems like one to watchMaybe now isn't the right time to enter, but i think this has potential for a long, at some point. Happy trading! Cheers!
Eventual upswingVery early analysis of a suspected trend change.
Coming month eventual upswing and potential opportunity to BUY.
Indicators point to oversold. Current down trend coming to a halt.
